SCHEMBL8285288

SCHEMBL8285288

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2c(Cc3ccccc3)cncc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 3/20 0.35
HPGD P15428 2/20 0.35
EGLN1 Q9GZT9 1/20 0.35
MAPK1 P28482 1/20 0.35
PDE11A Q9HCR9 1/20 0.35
CDK4 P11802 2/20 0.33
CCND1 P24385 2/20 0.33
CCND2 P30279 1/20 0.33
CCND3 P30281 1/20 0.33
MAT2A P31153 1/20 0.32
ALDH1A1 P00352 3/20 0.32
GSK3B P49841 1/20 0.32
TP53 P04637 1/20 0.32
MDM2 Q00987 1/20 0.32
MAPT P10636 1/20 0.32
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286554 0.90 ALDH1A1 (0.35) GAAHPGDEGLN1MAPK1PDE11A
SCHEMBL8287501 0.88 GAA (0.39) GAAHPGDMAPK1PDE11ACDK4
SCHEMBL8286155 0.88 KDM4E (0.37) NPC1GAAHPGDMAPK1PDE11A
SCHEMBL8286175 0.87 GAA (0.36) GAAHPGDMAPK1PDE11ACDK4
SCHEMBL8285362 0.87 GAA (0.36) GAAHPGDMAPK1PDE11ACDK4
SCHEMBL8285360 0.86 MAPT (0.41) GAAHPGDMAPK1PDE11ACDK4
SCHEMBL8285357 0.84 KCNJ6 (0.36) GAAHPGDMAPK1PDE11ACDK4
SCHEMBL8285350 0.84 GAA (0.36) GAAHPGDMAPK1PDE11ACDK4
SCHEMBL8286187 0.84 GAA (0.36) GAAHPGDMAPK1PDE11ACDK4
SCHEMBL8288000 0.84 PKM (0.35) GAAHPGDMAPK1PDE11ACDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed